Showing 201 - 220 results of 2,171 for search 'Who's Who in the World', query time: 0.07s Refine Results
  1. 201

    Frequency and types of antibiotic usage in a referral neonatal intensive care unit, based on the world health organization classification (AwaRe) by Farzaneh Hematian, Seyyed Mohammad Hassan Aletayeb, Masoud Dehdashtian, Mohammad Reza Aramesh, Arash Malakian, Mahboobeh Sadat Aletayeb

    Published 2025-01-01
    “…This study aimed to evaluate the dose and duration of antibiotic therapy and identify the prescribing pattern of antibiotics based on the Access, Watch, and Reserve (AWaRe) classification recommended by the World Health Organization (WHO). Results Out of 502 examined patient files, antibiotics were prescribed for 483 neonates. …”
    Get full text
    Article
  2. 202
  3. 203
  4. 204
  5. 205
  6. 206
  7. 207

    The Anti-Hitler Coalition: From Enmity to Military Alliance — A Formula for Success by A. Yu. Borisov

    Published 2020-11-01
    “…It is unfortunate to note again today that World War II did not end, it continues in the form of the war of memory. …”
    Get full text
    Article
  8. 208

    miR-182 promoter hypermethylation predicts the better outcome of AML patients treated with AZA + VEN in a real-world setting by Yilan Xu, Danyang Li, Na Wang, Bei Ge, Chen Meng, Min Zhao, Zihan Lin, Min Li, Yigang Yuan, Yue Cai, Liuzhi Shi, Shenmeng Gao, Haige Ye

    Published 2025-02-01
    “…Abstract Background 5-Azacytidine (AZA) combined with the BCL2 inhibitor Venetoclax (VEN) is the standard treatment for elderly acute myeloid leukemia (AML) patients or those who are unfit for intensive chemotherapy (elderly or unfit AML). …”
    Get full text
    Article
  9. 209

    Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology Setting by Benjamin H. Lowentritt, Carmine Rossi, Erik Muser, Frederic Kinkead, Bronwyn Moore, Patrick Lefebvre, Dominic Pilon, Shawn Du

    Published 2024-08-01
    “…**Objective:** To describe real-world treatment patterns and clinical outcomes among patients with mCSPC or nmCRPC who initiated apalutamide in the United States. …”
    Get full text
    Article
  10. 210
  11. 211
  12. 212
  13. 213

    Association between edaravone use and activities of daily living in older patients with atherothrombotic stroke: an observational study using Japanese real-world data by Yukari Ogawa, Hiroko Akiyama, Takeshi Horii, Kiyoshi Mihara

    Published 2025-01-01
    “…This study aimed to elucidate the association of edaravone use with ADL using real-world data of older patients with atherothrombotic stroke. …”
    Get full text
    Article
  14. 214
  15. 215
  16. 216
  17. 217
  18. 218

    Immune-related adverse events with PD-1/PD-L1 inhibitors: insights from a real-world cohort of 2523 patients by Ting Yan, Minghui Long, Chaoyi Liu, Jiwen Zhang, Jiwen Zhang, Xingyu Wei, Xingyu Wei, Fei Li, Fei Li, Dehua Liao

    Published 2025-01-01
    “…This study aims to investigate the prevalence and associated risk factors of irAEs in a real-world setting, as well as to assess their effects on optimal therapeutic outcomes.MethodsA retrospective analysis involved 2523 patients with cancer who received inpatient PD-1/PD-L1 inhibitors treatment between January 2018 and December 2022. …”
    Get full text
    Article
  19. 219
  20. 220